Jazz Pharmaceuticals Files 8-K
Ticker: JAZZ · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, sec-filing
Related Tickers: JAZZ
TL;DR
Jazz Pharma filed an 8-K with financial statements and exhibits. No major news.
AI Summary
On November 17, 2025, Jazz Pharmaceuticals plc filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant disclosures detailed in the provided text. The company is incorporated in Ireland and its principal executive offices are located in Dublin.
Why It Matters
This 8-K filing indicates Jazz Pharmaceuticals is submitting required financial statements and exhibits to the SEC. Investors should review the full filing for details on the company's financial health and any potential implications.
Risk Assessment
Risk Level: low — The filing is a routine submission of financial statements and exhibits, with no immediate indication of significant risks or material events.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- Ireland (location) — Jurisdiction of Incorporation
- Dublin (location) — Principal Executive Offices
- November 17, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Jazz Pharmaceuticals plc?
The primary purpose of this 8-K filing is to report financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on November 17, 2025.
Where are Jazz Pharmaceuticals plc's principal executive offices located?
Jazz Pharmaceuticals plc's principal executive offices are located in Dublin, Ireland.
What is the Commission File Number for Jazz Pharmaceuticals plc?
The Commission File Number for Jazz Pharmaceuticals plc is 001-33500.
What is the Standard Industrial Classification code for Jazz Pharmaceuticals plc?
The Standard Industrial Classification code for Jazz Pharmaceuticals plc is 2834 (Pharmaceutical Preparations).
Filing Stats: 453 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-11-17 06:28:37
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d827060d8k.htm (8-K) — 23KB
- d827060dex991.htm (EX-99.1) — 36KB
- g827060dsp1.jpg (GRAPHIC) — 5KB
- 0001193125-25-283887.txt ( ) — 193KB
- jazz-20251117.xsd (EX-101.SCH) — 3KB
- jazz-20251117_lab.xml (EX-101.LAB) — 18KB
- jazz-20251117_pre.xml (EX-101.PRE) — 11KB
- d827060d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated November 17, 2025. 104 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Neena M. Patil Name: Neena M. Patil Title: Executive Vice President and Chief Legal Officer Date: November 17, 2025